Validation of the Hospital Frailty Score in France

CompletedOBSERVATIONAL
Enrollment

1,000,000

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
ElderlyEmergency HospitalizationFrailty
Interventions
OTHER

None (retrospective observational study)

"This multi-centric retrospective observational cohort study is conducted using the PMSI. Predictive ability of HFRS estimated on the basis of 3 binary outcomes: 30-day in-patient mortality (main outcome), 30-day emergency and potentially avoidable readmission, length of stay \>15 days. Odds ratios (ORs) and c-statistics calculated and compared to the original UK results in order to validate the use of the HFRS in France. Other secondary objectives include:~* Evaluate agreement between HFRS and Charlson or Elixhauser comorbidity indices~* Evaluate ability of HFRS combined with comorbidity indices (Charlson on one hand, and Elixhauser on other hand), to predict 30-day in-patient mortality, 30-day emergency and potentially avoidable readmissions, and long length of stay~* Identify specific risk associations in France of a high risk of frailty (as assessed by the HFRS) with individual, organizational and territorial factors"

Trial Locations (1)

69495

service de court séjour gériatrique, Hôpital Lyon Sud, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03905629 - Validation of the Hospital Frailty Score in France | Biotech Hunter | Biotech Hunter